The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April ...

AVT06/AVT29 is a recombinant fusion protein and a biosimilar candidate to Eylea® (aflibercept ... Please click here for full Prescribing Information for SELARSDI. Teva Pharmaceutical Industries ...

Furthermore, Alvotech plans to launch biosimilars for Prolia, Symphony, and EYLEA, while exploring a ... of AI and reviewed by an editor. For more information see our T&C.

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of ...

for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and pediatric patients 6 years and older, and the treatment of adult patients with moderately to ...

When getting ready to take exams, it can sometimes feel as though there's no way all the information you need to remember is going to fit in your brain. But there are ways to create the right ...

Re­gen­eron can’t dodge a law­suit al­leg­ing it un­law­ful­ly in­flat­ed Medicare re­im­burse­ments for its eye drug Eylea and de­fraud­ed the US out of hun­dreds of mil­lions … ...

This component supplier has expeditiously responded to FDA requests for information. The CRL did not identify any issues with respect to the safety or efficacy of EYLEA HD, the usability of the ...

Q1 earnings and revenue miss expectations, mainly due to falling EYLEA sales. Stock rises on optimism around new drug approvals, pipeline progress, and upcoming FDA decisions. Don’t miss this ...

Beck of the Eastern District of Michigan. Valentine faced those charges for her role in prescribing medication during the time she was one of two primary doctors at the Orthopedic Medical Building ...